Patents expiring in 2030

US 7863456

Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid

PTC THERAPEUTICS, INC. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863414

Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain

The Board of Regents of the University of Texas System · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863041

Rabies virus vector systems and compositions and methods thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863047

Intracorporeal medicaments for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863262

Nitroxyl progenitors in the treatment of heart failure

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863275

Uses of tetrahydrobiopterin and derivatives thereof

The Board of Regents of the University of Texas System · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7862820

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7862811

Protease inhibition for prevention or treatment of heart failure

The Regents of the University of Colorado · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863309

Dual-acting antihypertensive agents

Theravance, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7862821

Recombinant vaccine against bluetongue virus

The Regents of the University of California · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7862815

Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863449

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863296

Selective serotonin receptor inverse agonists as therapeutics for disease

ACADIA Pharmaceuticals Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863282

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7862605

Coated implantable medical device

Cook Regentec LLC · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7863286

Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)